Cargando…

NASH-related increases in plasma bile acid levels depend on insulin resistance

BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Grzych, Guillaume, Chávez-Talavera, Oscar, Descat, Amandine, Thuillier, Dorothée, Verrijken, An, Kouach, Mostafa, Legry, Vanessa, Verkindt, Hélène, Raverdy, Violeta, Legendre, Benjamin, Caiazzo, Robert, Van Gaal, Luc, Goossens, Jean-Francois, Paumelle, Réjane, Francque, Sven, Pattou, François, Haas, Joel T., Tailleux, Anne, Staels, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878982/
https://www.ncbi.nlm.nih.gov/pubmed/33615207
http://dx.doi.org/10.1016/j.jhepr.2020.100222
_version_ 1783650437991235584
author Grzych, Guillaume
Chávez-Talavera, Oscar
Descat, Amandine
Thuillier, Dorothée
Verrijken, An
Kouach, Mostafa
Legry, Vanessa
Verkindt, Hélène
Raverdy, Violeta
Legendre, Benjamin
Caiazzo, Robert
Van Gaal, Luc
Goossens, Jean-Francois
Paumelle, Réjane
Francque, Sven
Pattou, François
Haas, Joel T.
Tailleux, Anne
Staels, Bart
author_facet Grzych, Guillaume
Chávez-Talavera, Oscar
Descat, Amandine
Thuillier, Dorothée
Verrijken, An
Kouach, Mostafa
Legry, Vanessa
Verkindt, Hélène
Raverdy, Violeta
Legendre, Benjamin
Caiazzo, Robert
Van Gaal, Luc
Goossens, Jean-Francois
Paumelle, Réjane
Francque, Sven
Pattou, François
Haas, Joel T.
Tailleux, Anne
Staels, Bart
author_sort Grzych, Guillaume
collection PubMed
description BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR). Here, we sought to dissect the relationship between NASH, T2D, and plasma BA levels in a large patient cohort. METHODS: Four groups of patients from the Biological Atlas of Severe Obesity (ABOS) cohort (Clinical Trials number NCT01129297) were included based on the presence or absence of histologically evaluated NASH with or without coincident T2D. Patients were matched for BMI, homeostatic model assessment 2 (HOMA2)-assessed IR, glycated haemoglobin, age, and gender. To study the effect of IR and BMI on the association of plasma BA and NASH, patients from the HEPADIP study were included. In both cohorts, fasting plasma BA concentrations were measured. RESULTS: Plasma BA concentrations were higher in NASH compared with No-NASH patients both in T2D and NoT2D patients from the ABOS cohort. As we previously reported that plasma BA levels were unaltered in NASH patients of the HEPADIP cohort, we assessed the impact of BMI and IR on the association of NASH and BA on the combined BA datasets. Our results revealed that NASH-associated increases in plasma total cholic acid (CA) concentrations depend on the degree of HOMA2-assessed systemic IR, but not on β-cell function nor on BMI. CONCLUSIONS: Plasma BA concentrations are elevated only in those NASH patients exhibiting pronounced IR. LAY SUMMARY: Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that frequently occurs in patients with obesity and type 2 diabetes. Reliable markers for the diagnosis of NASH are needed. Plasma bile acids have been proposed as NASH biomarkers. Herein, we found that plasma bile acids are only elevated in patients with NASH when significant insulin resistance is present, limiting their utility as NASH markers.
format Online
Article
Text
id pubmed-7878982
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78789822021-02-18 NASH-related increases in plasma bile acid levels depend on insulin resistance Grzych, Guillaume Chávez-Talavera, Oscar Descat, Amandine Thuillier, Dorothée Verrijken, An Kouach, Mostafa Legry, Vanessa Verkindt, Hélène Raverdy, Violeta Legendre, Benjamin Caiazzo, Robert Van Gaal, Luc Goossens, Jean-Francois Paumelle, Réjane Francque, Sven Pattou, François Haas, Joel T. Tailleux, Anne Staels, Bart JHEP Rep Research Article BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR). Here, we sought to dissect the relationship between NASH, T2D, and plasma BA levels in a large patient cohort. METHODS: Four groups of patients from the Biological Atlas of Severe Obesity (ABOS) cohort (Clinical Trials number NCT01129297) were included based on the presence or absence of histologically evaluated NASH with or without coincident T2D. Patients were matched for BMI, homeostatic model assessment 2 (HOMA2)-assessed IR, glycated haemoglobin, age, and gender. To study the effect of IR and BMI on the association of plasma BA and NASH, patients from the HEPADIP study were included. In both cohorts, fasting plasma BA concentrations were measured. RESULTS: Plasma BA concentrations were higher in NASH compared with No-NASH patients both in T2D and NoT2D patients from the ABOS cohort. As we previously reported that plasma BA levels were unaltered in NASH patients of the HEPADIP cohort, we assessed the impact of BMI and IR on the association of NASH and BA on the combined BA datasets. Our results revealed that NASH-associated increases in plasma total cholic acid (CA) concentrations depend on the degree of HOMA2-assessed systemic IR, but not on β-cell function nor on BMI. CONCLUSIONS: Plasma BA concentrations are elevated only in those NASH patients exhibiting pronounced IR. LAY SUMMARY: Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that frequently occurs in patients with obesity and type 2 diabetes. Reliable markers for the diagnosis of NASH are needed. Plasma bile acids have been proposed as NASH biomarkers. Herein, we found that plasma bile acids are only elevated in patients with NASH when significant insulin resistance is present, limiting their utility as NASH markers. Elsevier 2020-12-16 /pmc/articles/PMC7878982/ /pubmed/33615207 http://dx.doi.org/10.1016/j.jhepr.2020.100222 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Grzych, Guillaume
Chávez-Talavera, Oscar
Descat, Amandine
Thuillier, Dorothée
Verrijken, An
Kouach, Mostafa
Legry, Vanessa
Verkindt, Hélène
Raverdy, Violeta
Legendre, Benjamin
Caiazzo, Robert
Van Gaal, Luc
Goossens, Jean-Francois
Paumelle, Réjane
Francque, Sven
Pattou, François
Haas, Joel T.
Tailleux, Anne
Staels, Bart
NASH-related increases in plasma bile acid levels depend on insulin resistance
title NASH-related increases in plasma bile acid levels depend on insulin resistance
title_full NASH-related increases in plasma bile acid levels depend on insulin resistance
title_fullStr NASH-related increases in plasma bile acid levels depend on insulin resistance
title_full_unstemmed NASH-related increases in plasma bile acid levels depend on insulin resistance
title_short NASH-related increases in plasma bile acid levels depend on insulin resistance
title_sort nash-related increases in plasma bile acid levels depend on insulin resistance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878982/
https://www.ncbi.nlm.nih.gov/pubmed/33615207
http://dx.doi.org/10.1016/j.jhepr.2020.100222
work_keys_str_mv AT grzychguillaume nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT chaveztalaveraoscar nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT descatamandine nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT thuillierdorothee nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT verrijkenan nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT kouachmostafa nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT legryvanessa nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT verkindthelene nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT raverdyvioleta nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT legendrebenjamin nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT caiazzorobert nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT vangaalluc nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT goossensjeanfrancois nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT paumellerejane nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT francquesven nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT pattoufrancois nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT haasjoelt nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT tailleuxanne nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance
AT staelsbart nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance